CA952900A - Anti-inflammatory steroids of the pregnane series and processes for their preparation - Google Patents

Anti-inflammatory steroids of the pregnane series and processes for their preparation

Info

Publication number
CA952900A
CA952900A CA040,409A CA40409A CA952900A CA 952900 A CA952900 A CA 952900A CA 40409 A CA40409 A CA 40409A CA 952900 A CA952900 A CA 952900A
Authority
CA
Canada
Prior art keywords
processes
preparation
inflammatory steroids
pregnane series
pregnane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA040,409A
Other languages
English (en)
Inventor
Joseph Elks
Gordon H. Phillipps
Peter J. May
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Application granted granted Critical
Publication of CA952900A publication Critical patent/CA952900A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B7/00—Mountings, adjusting means, or light-tight connections, for optical elements
    • G02B7/20—Light-tight connections for movable optical elements
    • G02B7/22—Extensible connections, e.g. bellows

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Moulds For Moulding Plastics Or The Like (AREA)
CA040,409A 1968-01-19 1969-01-17 Anti-inflammatory steroids of the pregnane series and processes for their preparation Expired CA952900A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3100/68A GB1253831A (en) 1968-01-19 1968-01-19 9alpha,21-DIHALOPREGNANE COMPOUNDS

Publications (1)

Publication Number Publication Date
CA952900A true CA952900A (en) 1974-08-13

Family

ID=9751941

Family Applications (1)

Application Number Title Priority Date Filing Date
CA040,409A Expired CA952900A (en) 1968-01-19 1969-01-17 Anti-inflammatory steroids of the pregnane series and processes for their preparation

Country Status (14)

Country Link
US (1) US3721687A (nl)
BE (1) BE727109A (nl)
BR (1) BR6905681D0 (nl)
CA (1) CA952900A (nl)
CH (2) CH564563A5 (nl)
DK (1) DK126500B (nl)
ES (1) ES362679A1 (nl)
FR (1) FR2000443A1 (nl)
GB (1) GB1253831A (nl)
IE (1) IE33204B1 (nl)
IL (1) IL31447A (nl)
NL (1) NL6900795A (nl)
NO (1) NO132100C (nl)
SE (1) SE350035B (nl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
IT1194178B (it) * 1983-03-29 1988-09-14 Ricerche Steroidi Sirs Spa Soc Processo per la preparazione di 17-esteri di clobetasolo e composti ottenuti
ES2078175B1 (es) * 1993-12-31 1996-10-16 Cusi Lab Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
US20090304603A1 (en) * 2001-06-15 2009-12-10 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
US20040022741A1 (en) * 2001-06-15 2004-02-05 Crutchfield Charles E. Topical steroid spray
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
CA2664247A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
MX2009009793A (es) * 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
WO2009045539A2 (en) 2007-10-05 2009-04-09 Nektar Therapeutics Al, Corporation Oligomer-corticosteroid conjugates
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN101812107B (zh) * 2010-04-20 2013-05-01 浙江仙居仙乐药业有限公司 一种合成丙酸氯倍他索的方法
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same

Also Published As

Publication number Publication date
FR2000443A1 (nl) 1969-09-05
DK126500B (da) 1973-07-23
IE33204B1 (en) 1974-04-17
BE727109A (nl) 1969-07-22
SE350035B (nl) 1972-10-16
CH564035A5 (nl) 1975-07-15
DE1902340B2 (de) 1977-06-08
NO132100C (nl) 1975-09-17
US3721687A (en) 1973-03-20
BR6905681D0 (pt) 1973-02-08
DE1902340A1 (de) 1969-09-11
ES362679A1 (es) 1971-02-01
NL6900795A (nl) 1969-07-22
NO132100B (nl) 1975-06-09
IL31447A0 (en) 1969-03-27
IE33204L (en) 1969-07-19
CH564563A5 (nl) 1975-07-31
GB1253831A (en) 1971-11-17
IL31447A (en) 1973-11-28

Similar Documents

Publication Publication Date Title
CA952900A (en) Anti-inflammatory steroids of the pregnane series and processes for their preparation
AU473714B2 (en) Anti-inflammatory steroids of the androstane series
IL38378A0 (en) Steroids of the androstane series and their preparation
IL41160A0 (en) Novel steroids of the pregnane series and their preparation
CA1006156A (en) Steroids of the pregnane series
CA918636A (en) Steroids of the pregnane series
IL31870A0 (en) New steroid esters of the pregnane series and process of preparation
CA955931A (en) Steroids of the pregnane series
CA940917A (en) 18-methylene-steroids of the pregnane series and process for their manufacture
CA792233A (en) Steroid derivatives of the pregnane or allopregnane series
IL36213A0 (en) 20-hydroxylated steroid derivatives of the pregnane series and process of preparation
IL36164A0 (en) Novel steroids of the pregnane series and process for the preparation of same
CA799465A (en) Process for the manufacture of steroids of the pregnane series
CA778356A (en) Esters of steroid 17-sulfoacetates of the androstane and estrane series
CA709838A (en) 21-nitrogen substituted steroids of the pregnane series and methods of preparing the same
CA764958A (en) 6-fluoromethyl steroids of the pregnane series
AU451348B2 (en) Novel steroids of the pregnane series
CA720330A (en) 6-fluoromethyl steroids of the pregnane series
CA952100A (en) 18-methylene-steroids of the pregnane series and process for their manufacture
CA995663A (en) Anti-inflammatory steroid and processes for its preparation
CA732171A (en) Steroid lactones of the androstane and estrane series
CA892572A (en) Steroids of the pregnane series
CA832442A (en) 17 alpha-alkylated steroids of the pregnane series
AU290249B2 (en) 1 new steroids ofthe pregnane series and processes for their manufacture
CA754552A (en) 1-DEHYDRO-16.alpha.-FLUOROMETHYL STEROIDS OF THE PREGNANE SERIES AND PROCESS